140 related articles for article (PubMed ID: 12271430)
1. Pretherapeutic assessment of tumour metabolism using a dual tracer PET technique.
Brunkhorst T; Boerner AR; Bergh S; Otto D; Gratz FW; Knapp WH
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1416. PubMed ID: 12271430
[No Abstract] [Full Text] [Related]
2. Unsuspected Metastases to Muscles in Osteosarcoma Detected on 18F-Sodium Fluoride PET-CT.
Usmani S; Marafi F; Rasheed R; Bakiratharajan D; Al Maraghy M; Al Kandari F
Clin Nucl Med; 2018 Sep; 43(9):e343-e345. PubMed ID: 30080191
[TBL] [Abstract][Full Text] [Related]
3. PET tracers for osteosarcoma.
Reiman RE
J Nucl Med; 2004 Aug; 45(8):1424; author reply 1424-5. PubMed ID: 15299071
[No Abstract] [Full Text] [Related]
4. (99m)Tc-MDP uptake in soft-tissue osteosarcoma in a dog.
Lass P; Krzemiński M; Teodorczyk J
Nucl Med Rev Cent East Eur; 2004; 7(2):189. PubMed ID: 15968610
[No Abstract] [Full Text] [Related]
5. [Computed tomography of the thoracic organs].
Gabuniia RI; Kolesnikova EK; Tumanov LB
Vestn Rentgenol Radiol; 1983; (1):12-8. PubMed ID: 6573815
[No Abstract] [Full Text] [Related]
6. Positron emission tomography and the orthopaedic surgeon.
Smith MA; O'Doherty MJ
J Bone Joint Surg Br; 2000 Apr; 82(3):324-5. PubMed ID: 10813162
[No Abstract] [Full Text] [Related]
7. [Problems of differential diagnosis in the diagnosis of mediastinal and pulmonary metastases with F-a8-FDG PET].
Adams S; Nickel E; Hör G
Nuklearmedizin; 2000 Aug; 39(5):N83-4. PubMed ID: 10984898
[No Abstract] [Full Text] [Related]
8. PET imaging of osteosarcoma.
Brenner W; Bohuslavizki KH; Eary JF
J Nucl Med; 2003 Jun; 44(6):930-42. PubMed ID: 12791822
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.
Schulte M; Brecht-Krauss D; Werner M; Hartwig E; Sarkar MR; Keppler P; Kotzerke J; Guhlmann A; Delling G; Reske SN
J Nucl Med; 1999 Oct; 40(10):1637-43. PubMed ID: 10520703
[TBL] [Abstract][Full Text] [Related]
10. The scintigraphic detection of ossific mediastinal and pulmonary metastases in osteosarcoma.
Brady AP; Ennis JT
Br J Radiol; 1990 Dec; 63(756):978-80. PubMed ID: 2268771
[No Abstract] [Full Text] [Related]
11. F-18 fluoride uptake in calcified extraosseous metastases from ovarian papillary serous adenocarcinoma.
Agrawal K; Bhattacharya A; Harisankar CN; Abrar ML; Dhaliwal LK; Mittal BR
Clin Nucl Med; 2012 Jan; 37(1):e22-3. PubMed ID: 22157054
[No Abstract] [Full Text] [Related]
12. Positron emission tomography diagnosis of pulmonary metastases in osteogenic sarcoma.
Tse N; Hoh C; Hawkins R; Phelps M; Glaspy J
Am J Clin Oncol; 1994 Feb; 17(1):22-5. PubMed ID: 8311003
[TBL] [Abstract][Full Text] [Related]
13. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.
Shreve PD; Grossman HB; Gross MD; Wahl RL
Radiology; 1996 Jun; 199(3):751-6. PubMed ID: 8638000
[TBL] [Abstract][Full Text] [Related]
14. [Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft tissue tumors. 3rd Interdisciplinary Consensus Conference "PET in Oncology": results of the Bone and Soft Tissue Study Group].
Franzius C; Schulte M; Hillmann A; Winkelmann W; Jürgens H; Bockisch A; Schober O
Chirurg; 2001 Sep; 72(9):1071-7. PubMed ID: 11594280
[TBL] [Abstract][Full Text] [Related]
15. Bone scan appearance in aggressive osteogenic sarcoma with pleural, lung, bone, and soft-tissue metastases.
Othman S; El-Desouki M
Clin Nucl Med; 2003 Nov; 28(11):926. PubMed ID: 14578712
[TBL] [Abstract][Full Text] [Related]
16. Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
Kushner BH; Yeung HW; Larson SM; Kramer K; Cheung NK
J Clin Oncol; 2001 Jul; 19(14):3397-405. PubMed ID: 11454888
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.
Tian M; Zhang H; Oriuchi N; Higuchi T; Endo K
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1064-72. PubMed ID: 15014903
[TBL] [Abstract][Full Text] [Related]
18. In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging.
Sarlis NJ; Gourgiotis L; Guthrie LC; Galen B; Skarulis MC; Shawker TH; Patronas NJ; Reynolds JC
Clin Nucl Med; 2003 Mar; 28(3):208-17. PubMed ID: 12592128
[TBL] [Abstract][Full Text] [Related]
19. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
20. PET scanning said to save money and improve staging of lung cancer.
Oncology (Williston Park); 1995 Nov; 9(11):1200. PubMed ID: 8703689
[No Abstract] [Full Text] [Related]
[Next] [New Search]
